United States: Competition EO: President Biden's Prescription For Antitrust Concerns In Healthcare And Life Sciences Industries - Winston & Strawn LLP

Mondaq

26 Jul 2021 0 shares 1 views

United States: Competition EO: President Biden's Prescription For Antitrust Concerns In Healthcare And Life Sciences Industries - Winston & Strawn LLP

Mondaq

Published 26 Jul 2021

On July 9, 2021, President Biden issued the "Executive Order on Promoting Competition in the American Economy" (the Order) and the White House's contemporaneous Fact Sheet...

Full Article

United States: Preparing For The Next Time: Health Care Consolidation And Antitrust Strategies After The Pandemic - Winston & Strawn LLP

Mondaq 26 Jul 2021

By all accounts, the consolidation that has dominated the health care provider industry will continue—if not accelerate—after..

United States: Competition EO: Eyes On Banking - Winston & Strawn LLP
Mondaq 26 Jul 2021
United States: President Biden's Executive Order On Competition: Three Important Takeaways For Tech And Life Sciences Companies - Cooley LLP
Mondaq 23 Jul 2021
United States: Competition EO: Initiatives Targeting Airlines And Transportation Industry - Winston & Strawn LLP
Mondaq 22 Jul 2021
United States: Competition EO: Spotlight On Anticompetitive Concerns In Labor Markets - Winston & Strawn LLP
Mondaq 21 Jul 2021

United States: Competition EO: President Biden's Prescription For Antitrust Concerns In Healthcare And Life Sciences Industries - Winston & Strawn LLP

United States: Competition EO: President Biden's Prescription For Antitrust Concerns In Healthcare And Life Sciences Industries - Winston & Strawn LLP

You might like

Related news coverage

United States: Preparing For The Next Time: Health Care Consolidation And Antitrust Strategies After The Pandemic - Winston & Strawn LLP

Advertisement

More coverage